Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Patrick Burnett Plans to Sell 943 Arcutis Shares

Arcutis Biotherapeutics, Inc. officer Patrick Burnett filed a Form 144 notice of proposed sale of securities on November 2, 2026, disclosing plans to sell 943 shares of common stock on NASDAQ.

Anjali Anand | 02 November 2026

Metallus Officer Syrvalin Files to Sell 9,092 Shares

Kristine Syrvalin, an officer of Metallus Inc., filed a Form 144 notice of proposed sale of securities on November 2, 2026, covering 9,092 shares of common stock with an aggregate market value of $200,024.

Vinay Lochav | 02 November 2026

Nonko Files to Sell 632,572 MediaAlpha Shares

Director Eugene Nonko filed a Form 144 notice of proposed sale with the SEC on November 2, 2026, disclosing plans to sell 632,572 shares of MediaAlpha, Inc. common stock on NYSE:MAX through Charles Schwab & Co., Inc.

Anjali Anand | 02 November 2026

Diversified Healthcare Trust Posts Q3 2026 Net Loss of $50.2M

Diversified Healthcare Trust filed its quarterly report on Form 10-Q with the SEC on November 2, 2026, covering the period ended September 30, 2026, disclosing a net loss of $50,229 thousand for the third quarter and total revenues of $367,670 thousand.

Vinay Lochav | 02 November 2026

MediaAlpha Officer Steven Yi Plans Sale of 398,033 Shares

Steven Yi, an officer and director of MediaAlpha, Inc., filed a Form 144 notice on November 2, 2026, disclosing a proposed sale of 398,033 shares of MediaAlpha common stock through Charles Schwab & Co., Inc.

Anjali Anand | 02 November 2026

Metallus Officer Raketich Plans to Sell 22,800 Shares

Kevin Raketich, an officer of Metallus Inc., filed a Form 144 notice on November 2, 2026, proposing the sale of 22,800 shares of Metallus common stock through a Rule 10b5-1 trading plan adopted on May 12, 2026.

Vinay Lochav | 02 November 2026

Arcutis Officer Watanabe Files to Sell 4,377 Shares

Todd Franklin Watanabe, an officer of Arcutis Biotherapeutics, Inc., filed a Form 144 notice on November 2, 2026, proposing the sale of 4,377 shares of common stock on NASDAQ.

Vinay Lochav | 02 November 2026

Boston Scientific Q3 2026: Net Sales Rise to $5.138B

Boston Scientific Corporation filed its quarterly report on Form 10-Q with the SEC on November 2, 2026, covering the three and nine months ended September 30, 2026, and reporting net sales of $5.138 billion for the third quarter.

Aditi Sarkar | 02 November 2026

i-80 Gold Files Q3 2026 10-Q With 868 Million Shares Out

i-80 Gold Corp. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the U.S. Securities and Exchange Commission on November 2, 2026, disclosing share count, operational developments, and forward-looking guidance related to its Nevada gold mining assets.

Nitish Kishor | 02 November 2026

Roper Technologies Q3 2026: Revenue $2.17B, EPS $4.88

Roper Technologies, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 2, 2026, reporting third-quarter net revenues of $2,171.8 million and diluted earnings per share of $4.88.

Aakashdeep | 02 November 2026
Support

Hi! How can we help you today?

Loading…